Stephen D. Hess

2.6k total citations · 1 hit paper
38 papers, 2.1k citations indexed

About

Stephen D. Hess is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Dermatology. According to data from OpenAlex, Stephen D. Hess has authored 38 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 16 papers in Cellular and Molecular Neuroscience and 7 papers in Dermatology. Recurrent topics in Stephen D. Hess's work include Neuroscience and Neuropharmacology Research (13 papers), Ion channel regulation and function (9 papers) and Cutaneous lymphoproliferative disorders research (5 papers). Stephen D. Hess is often cited by papers focused on Neuroscience and Neuropharmacology Research (13 papers), Ion channel regulation and function (9 papers) and Cutaneous lymphoproliferative disorders research (5 papers). Stephen D. Hess collaborates with scholars based in United States, United Kingdom and Germany. Stephen D. Hess's co-authors include Edwin C. Johnson, Gönül Veliçelebi, Mark A. Varney, Sara Rao, Peter J. Flor, Aida Sacaan, Richard B. Bankert, Nejat K. Egilmez, Hans Allgeier and Rainer Kühn and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Immunology and Scientific Reports.

In The Last Decade

Stephen D. Hess

37 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist

1999 628 citations F. Gasparini, Kurt Lingenhöhl et al. Neuropharmacology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stephen D. Hess United States	20	1.1k	917	383	328	227	38	2.1k
Kun Huang Canada	20	1.0k 0.9×	1.5k 1.6×	55 0.1×	117 0.4×	186 0.8×	53	2.5k
Abigail S. Hackam United States	34	2.3k 2.0×	3.1k 3.4×	49 0.1×	227 0.7×	201 0.9×	76	4.2k
Linda Czyzyk United States	8	693 0.6×	1.4k 1.6×	54 0.1×	92 0.3×	800 3.5×	9	2.1k
Michel J. Roux France	26	1.1k 0.9×	1.5k 1.6×	30 0.1×	77 0.2×	68 0.3×	73	2.3k
Gerard M. J. Beaudoin United States	15	400 0.3×	694 0.8×	63 0.2×	53 0.2×	43 0.2×	20	1.3k
Benjamin D. McNeil United States	15	504 0.4×	853 0.9×	531 1.4×	1.0k 3.1×	30 0.1×	16	2.6k
Avtar Roopra United States	27	572 0.5×	1.6k 1.7×	21 0.1×	89 0.3×	146 0.6×	55	2.5k
Ashok N. Hegde United States	27	847 0.7×	1.7k 1.9×	24 0.1×	80 0.2×	192 0.8×	50	2.5k
Sunil Mehta United States	18	605 0.5×	1.2k 1.3×	17 0.0×	132 0.4×	73 0.3×	36	1.9k
Kevin A. Kelley United States	28	381 0.3×	1.2k 1.3×	15 0.0×	379 1.2×	295 1.3×	50	2.3k

Countries citing papers authored by Stephen D. Hess

Since Specialization

Citations

This map shows the geographic impact of Stephen D. Hess's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen D. Hess with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen D. Hess more than expected).

Fields of papers citing papers by Stephen D. Hess

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen D. Hess. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen D. Hess. The network helps show where Stephen D. Hess may publish in the future.

Co-authorship network of co-authors of Stephen D. Hess

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen D. Hess. A scholar is included among the top collaborators of Stephen D. Hess based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen D. Hess. Stephen D. Hess is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zaliani, Andrea, Undine Haferkamp, Anne Willing, et al.. (2024). Identification and development of TRPM4 antagonists to counteract neuronal excitotoxicity. iScience. 27(12). 111425–111425. 1 indexed citations

Davenport, Adam J., Ioana Berindan‐Neagoe, Markus Koch, et al.. (2021). Eliapixant is a selective P2X3 receptor antagonist for the treatment of disorders associated with hypersensitive nerve fibers. Scientific Reports. 11(1). 19877–19877. 40 indexed citations

Petrie, Matthew S., Stephen D. Hess, & Anthony V. Benedetto. (2011). Automated 15-Minute Cytokeratin 7 Immunostaining Protocol for Extramammary Paget's Disease in Mohs Micrographic Surgery. Dermatologic Surgery. 37(12). 1811–1815. 9 indexed citations

Jambusaria‐Pahlajani, Anokhi, Stephen D. Hess, Kenneth A. Katz, Daniel Berg, & Chrysalyne D. Schmults. (2010). Uncertainty in the Perioperative Management of High-Risk Cutaneous Squamous Cell Carcinoma Among Mohs Surgeons. Archives of Dermatology. 146(11). 1225–1231. 39 indexed citations

Treat, James R., Stephen D. Hess, Karin L. McGowan, Albert C. Yan, & Carrie Kovarik. (2010). Ulceroglandular Tularemia. Pediatric Dermatology. 28(3). 318–320. 3 indexed citations

Piper, David R., William J. Frazee, Elizabeth A. Frey, et al.. (2008). Development of the Predictor hERG Fluorescence Polarization Assay Using a Membrane Protein Enrichment Approach. Assay and Drug Development Technologies. 6(2). 213–223. 37 indexed citations

Wysocka, Maria, Andrea B. Troxel, Stephen D. Hess, et al.. (2007). IL-21 Enhances Antitumor Responses without Stimulating Proliferation of Malignant T Cells of Patients with Sézary Syndrome. Journal of Investigative Dermatology. 128(2). 473–480. 14 indexed citations

Kim, Ellen J., Stephen D. Hess, Stephen K. Richardson, et al.. (2005). Immunopathogenesis and therapy of cutaneous T cell lymphoma. Journal of Clinical Investigation. 115(4). 798–812. 310 indexed citations

Introcaso, Camille E., Stephen D. Hess, Malek Kamoun, et al.. (2005). Association of change in clinical status and change in the percentage of the CD4+CD26− lymphocyte population in patients with Sézary syndrome. Journal of the American Academy of Dermatology. 53(3). 428–434. 19 indexed citations

10.

Hess, Stephen D., Nejat K. Egilmez, Timothy Anderson, et al.. (2003). Human CD4+ T Cells Present Within the Microenvironment of Human Lung Tumors Are Mobilized by the Local and Sustained Release of IL-12 to Kill Tumors In Situ by Indirect Effects of IFN-γ. The Journal of Immunology. 170(1). 400–412. 57 indexed citations

11.

Varney, Mark A., Fen‐Fen Lin, Christine Jachec, et al.. (2003). Stable Expression of Human NMDA Receptors in Cultured Mammalian Cells. Humana Press eBooks. 128. 43–59. 4 indexed citations

12.

Bankert, Richard B., Nejat K. Egilmez, & Stephen D. Hess. (2001). Human–SCID mouse chimeric models for the evaluation of anti-cancer therapies. Trends in Immunology. 22(7). 386–393. 72 indexed citations

13.

Egilmez, Nejat K., Yong S. Jong, Stephen D. Hess, et al.. (2000). Cytokines Delivered by Biodegradable Microspheres Promote Effective Suppression of Human Tumors by Human Peripheral Blood Lymphocytes in the SCID–Winn Model. Journal of Immunotherapy. 23(2). 190–195. 23 indexed citations

14.

Veliçelebi, Gönül, Kenneth A. Stauderman, Mark A. Varney, et al.. (1999). [2] Fluorescence techniques for measuring ion channel activity. Methods in enzymology on CD-ROM/Methods in enzymology. 294. 20–47. 23 indexed citations

15.

Gasparini, F., Valeria Bruno, Giuseppe Battaglia, et al.. (1999). (R, S)-4-Phosphonophenylglycine, a Potent and Selective Group III Metabotropic Glutamate Receptor Agonist, Is Anticonvulsive and Neuroprotective In Vivo. Journal of Pharmacology and Experimental Therapeutics. 289(3). 1678–1687. 143 indexed citations

16.

Gasparini, F., Kurt Lingenhöhl, Natacha Stoehr, et al.. (1999). 2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist. Neuropharmacology. 38(10). 1493–1503. 628 indexed citations breakdown →

17.

Daggett, Lorrie P., Edwin C. Johnson, Mark A. Varney, et al.. (1998). The Human N‐Methyl‐d‐Aspartate Receptor 2C Subunit: Genomic Analysis, Distribution in Human Brain, and Functional Expression. Journal of Neurochemistry. 71(5). 1953–1968. 22 indexed citations

18.

Varney, Mark A., Sara Rao, Christine Jachec, et al.. (1998). Pharmacological Characterization of the Human Ionotropic Glutamate Receptor Subtype GluR3 Stably Expressed in Mammalian Cells. Journal of Pharmacology and Experimental Therapeutics. 285(1). 358–370. 17 indexed citations

19.

Hess, Stephen D., et al.. (1998). Functional Characterization of Human N‐Methyl‐d‐Aspartate Subtype 1A/2D Receptors. Journal of Neurochemistry. 70(3). 1269–1279. 28 indexed citations

20.

Daggett, Lorrie P., Aida Sacaan, M. Akong, et al.. (1995). Molecular and functional characterization of recombinant human metabotropic glutamate receptor subtype 5. Neuropharmacology. 34(8). 871–886. 102 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact